Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 47
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Environ Sci Technol ; 58(23): 10368-10377, 2024 Jun 11.
Artículo en Inglés | MEDLINE | ID: mdl-38814143

RESUMEN

The insect Tenebrio molitor exhibits ultrafast efficiency in biodegrading polystyrene (PS). However, the generation and fate of nanoplastics (NPs) in the intestine during plastic biodegradation remain unknown. In this study, we investigated the biodegradation of PS microplastics (MPs) mediated by T. molitor larvae over a 4-week period and confirmed biodegradation by analyzing Δδ13C in the PS before and after biotreatment (-28.37‰ versus -24.88‰) as an effective tool. The ·OH radicals, primarily contributed by gut microbiota, and H2O2, primarily produced by the host, both increased after MP digestion. The size distribution of residual MP particles in excrements fluctuated within the micrometer ranges. PS NPs were detected in the intestine but not in the excrements. At the end of Weeks 1, 2, 3, and 4, the concentrations of PS NPs in gut tissues were 3.778, 2.505, 2.087, and 2.853 ng/lava, respectively, while PS NPs in glands were quantified at 0.636, 0.284, and 0.113 ng/lava and eventually fell below the detection limit. The PS NPs in glands remained below the detection limit at the end of Weeks 5 and 6. This indicates that initially, NPs generated in the gut entered glands, then declined gradually and eventually disappeared or possibly biodegraded after Week 4, associated with the elevated plastic-degrading capacities of T. molitor larvae. Our findings unveil rapid synergistic MP biodegradation by the larval host and gut microbiota, as well as the fate of generated NPs, providing new insights into the risks and fate associated with NPs during invertebrate-mediated plastic biodegradation.


Asunto(s)
Biodegradación Ambiental , Larva , Microplásticos , Poliestirenos , Tenebrio , Animales , Microplásticos/metabolismo , Tenebrio/metabolismo , Larva/metabolismo , Plásticos/metabolismo , Microbioma Gastrointestinal
2.
J Environ Manage ; 345: 118818, 2023 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-37633102

RESUMEN

It is widely understood that microplastics (MPs) can induce various biological stresses in macroinvertebrates that are incapable of biodegrading plastics. However, the biodegradation and physiological responses of plastic-degrading macroinvertebrates toward MPs of different degradability levels remain unexplored. In this study, Tenebrio molitor larvae (mealworms) were selected as a model of plastics-degrading macroinvertebrate, and were tested against three common plastics of different degradability rankings: polyvinyl chloride (PVC), polystyrene (PS), and polylactic acid (PLA) MPs (size <300 µm). These three MPs were biodegraded with the rate sequence of PLA > PS > PVC, resulting in a reversed order of negative physiological responses (body weight loss, decreased survival, and biomass depletion) of mealworms. Simultaneously, the levels of reactive oxygen species (ROS), antioxidant enzyme activities, and lipid peroxidation were uniformly increased as polymer degradability decreased and intermediate toxicity increased. PVC MPs exhibited higher toxicity than the other two polymers. The oxidative stresses were effectively alleviated by supplementing co-diet bran. The T. molitor larvae fed with PLA plus bran showed sustainable growth without an increase in oxidative stress. The results provide new insights into the biotoxicity of MPs on macroinvertebrates and offer comprehensive information on the physiological stress responses of plastic-degrading macroinvertebrates during the biodegradation of plastics with different degradability levels.


Asunto(s)
Poliestirenos , Tenebrio , Animales , Poliestirenos/toxicidad , Larva/metabolismo , Tenebrio/metabolismo , Plásticos , Microplásticos/toxicidad , Microplásticos/metabolismo , Cloruro de Polivinilo , Poliésteres/metabolismo , Antioxidantes/metabolismo
3.
Food Microbiol ; 98: 103573, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-33875193

RESUMEN

Chinese Sichuan Paocai (CSP) is one of the world's best-known fermented vegetables with a large presence in the Chinese market. The dynamic microbial community is the main contributor to Paocai fermentation. However, little is known about the ecological distribution and functional importance of these community members. In this study, metatranscriptomics was used to comprehensively explore the active microbial community members and key transcripts with significant functions in the Paocai fermentation process. Enterobacter, Leuconostoc, and Lactobacillus dominated the three-fermentation stages (Pre-, Mid- and Lat-), respectively. Carbon metabolism was the most abundant pathway. GH (glycoside hydrolase) and GT (lycosyl transferase) were the two most highly expressed carbohydrate-active enzymes. The most highly differentially expressed genes were grouped in the biosynthesis of amino acids, followed by glycolysis. Meta-pathways in the Sichuan Paocai fermentation ecosystem were reconstructed, Lactobacillaceae and Enterobacteriaceae were the two most important metabolic contributors. In addition, the nrfA and nirB were two genes referred to distinct nitrite reductase enzymes and 9 specialized genes, such as eclo, ron and ent were expressed to produce autoinducer 2 (AI-2) kinase in response to population density. The present study revealed functional enzymes and meta-pathways of the active microbial communities, which provide a deeper understanding of their contribution to CSP products.


Asunto(s)
Brassica/microbiología , Enterobacteriaceae/aislamiento & purificación , Enterobacteriaceae/metabolismo , Alimentos Fermentados/microbiología , Lactobacillaceae/aislamiento & purificación , Microbiota , Verduras/microbiología , Brassica/metabolismo , China , Enterobacteriaceae/clasificación , Enterobacteriaceae/genética , Fermentación , Microbiología de Alimentos , Lactobacillaceae/clasificación , Lactobacillaceae/genética , Lactobacillaceae/metabolismo , Metagenómica , Transcriptoma , Verduras/metabolismo
4.
Acta Pharmacol Sin ; 41(5): 730, 2020 05.
Artículo en Inglés | MEDLINE | ID: mdl-32081978

RESUMEN

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

5.
Angew Chem Int Ed Engl ; 59(6): 2429-2439, 2020 02 03.
Artículo en Inglés | MEDLINE | ID: mdl-31782597

RESUMEN

Benzoxepane derivatives were designed and synthesized, and one hit compound emerged as being effective in vitro with low toxicity. In vivo, this hit compound ameliorated both sickness behavior through anti-inflammation in LPS-induced neuroinflammatory mice model and cerebral ischemic injury through anti-neuroinflammation in rats subjected to transient middle cerebral artery occlusion. Target fishing for the hit compound using photoaffinity probes led to identification of PKM2 as the target protein responsible for anti-inflammatory effect of the hit compound. Furthermore, the hit exhibited an anti-neuroinflammatory effect in vitro and in vivo by inhibiting PKM2-mediated glycolysis and NLRP3 activation, indicating PKM2 as a novel target for neuroinflammation and its related brain disorders. This hit compound has a better safety profile compared to shikonin, a reported PKM2 inhibitor, identifying it as a lead compound in targeting PKM2 for the treatment of inflammation-related diseases.


Asunto(s)
Antiinflamatorios/síntesis química , Dibenzoxepinas/química , Animales , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Dibenzoxepinas/farmacología , Dibenzoxepinas/uso terapéutico , Modelos Animales de Enfermedad , Infarto de la Arteria Cerebral Media/complicaciones , Infarto de la Arteria Cerebral Media/patología , Interleucina-1beta/genética , Interleucina-1beta/metabolismo , Accidente Cerebrovascular Isquémico/tratamiento farmacológico , Accidente Cerebrovascular Isquémico/etiología , Lipopolisacáridos/toxicidad , Macrófagos/citología , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Ratones , Microglía/citología , Microglía/efectos de los fármacos , Microglía/metabolismo , Proteína con Dominio Pirina 3 de la Familia NLR/metabolismo , Naftoquinonas/uso terapéutico , Piruvato Quinasa/antagonistas & inhibidores , Piruvato Quinasa/metabolismo , Células RAW 264.7 , Ratas , Relación Estructura-Actividad , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/metabolismo
6.
J Neurochem ; 150(3): 282-295, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-31121068

RESUMEN

Neuroinflammation is one of the driving forces of progressive neurodegeneration in Parkinson's disease (PD). The metabolomics approach has been proved highly useful in identifying potential therapeutic targets. Here, to identify inflammation-relevant treatment targets for PD, mass spectrometry-based untargeted metabolomics was applied to characterize metabolic changes in the striatum of mice with double-hit PD induced by lipopolysaccharide plus 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Seven days after the final MPTP administration, metabolites from the purine metabolism pathway, including adenosine, 1-methyladenosine, adenine, inosine, hypoxanthine, xanthine, xanthosine, and guanosine, were found to be significantly dysregulated. The metabolite-protein interaction network and changes in the concentration ratio of these metabolites indicated that adenosine and adenosine deaminase (ADA; EC 3.5.4.4) were the most promising therapeutic targets and adenosine augmentation might be a rational approach to slow PD progression. These findings were then verified in a subacute MPTP-induced PD mouse model treated with ADA inhibition alone or in conjunction with antagonism of adenosine A2A receptors (A2A R). Behavioral, biochemical, and immunohistochemical analysis demonstrated that ADA inhibition significantly ameliorated the MPTP-mediated motor disabilities, dopamine depletion, and dopaminergic cell death. Significantly enhanced neuroprotective effects were further observed when the ADA inhibitor was utilized in conjunction with an A2A R antagonist. Together, our study indicated for the first time that ADA inhibitors protected against neurodegeneration induced by the neurotoxin MPTP, and ADA inhibitors in combination with A2A R antagonists showed additive antiparkinsonian effects.


Asunto(s)
Inhibidores de la Adenosina Desaminasa/farmacología , Adenosina Desaminasa/metabolismo , Antiparkinsonianos/farmacología , Trastornos Parkinsonianos/metabolismo , Animales , Modelos Animales de Enfermedad , Masculino , Metabolómica , Ratones , Ratones Endogámicos C57BL , Antagonistas de Receptores Purinérgicos P1/farmacología
7.
Cell Mol Neurobiol ; 39(2): 265-286, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30607811

RESUMEN

Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a long non-coding RNA contributing to protect the blood-brain barrier (BBB) after stroke. We searched for small molecules that may up-regulate MALAT1 and focused on polydatin (PD), a natural product, as a possible candidate. PD enhanced MALAT1 gene expression in rat brain microvascular endothelial cells, reducing cell toxicity and apoptosis after oxygen and glucose deprivation (OGD). These effects correlated with reduction of inflammatory factors and enhancement of expression of BBB markers. We found opposite changes after MALAT1 silencing. We determined that C/EBPß is a key transcription factor for PD-mediated MALAT1 expression. PPARγ activity is involved in MALAT1 protective effects through its coactivator PGC-1α and the transcription factor CREB. This suggests that PD activates the MALAT1/CREB/PGC-1α/PPARγ signaling pathway to protect endothelial cells against ischemia. PD administration to rats subjected to brain ischemia by transient middle cerebral artery occlusion (tMCAO) reduced cerebral infarct volume and brain inflammation, protected cerebrovascular endothelial cells and BBB integrity. These effects correlated with increased expression of MALAT1, C/EBPß, and PGC-1α. Our results strongly suggest that the beneficial effects of PD involve the C/EBPß/MALAT1/CREB/PGC-1α/PPARγ pathway, which may provide a novel therapeutic strategy for brain ischemic stroke.


Asunto(s)
Encéfalo/irrigación sanguínea , Proteína beta Potenciadora de Unión a CCAAT/metabolismo , Glucósidos/uso terapéutico , Microvasos/metabolismo , PPAR gamma/metabolismo , Coactivador 1-alfa del Receptor Activado por Proliferadores de Peroxisomas gamma/metabolismo , ARN Largo no Codificante/genética , Estilbenos/uso terapéutico , Accidente Cerebrovascular/tratamiento farmacológico , Animales , Secuencia de Bases , Barrera Hematoencefálica/efectos de los fármacos , Barrera Hematoencefálica/metabolismo , Barrera Hematoencefálica/patología , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/metabolismo , Glucósidos/química , Glucósidos/farmacología , Células HEK293 , Células Endoteliales de la Vena Umbilical Humana/efectos de los fármacos , Células Endoteliales de la Vena Umbilical Humana/metabolismo , Células Endoteliales de la Vena Umbilical Humana/patología , Humanos , Infarto de la Arteria Cerebral Media/metabolismo , Infarto de la Arteria Cerebral Media/patología , Modelos Biológicos , ARN Largo no Codificante/metabolismo , Ratas Sprague-Dawley , Estilbenos/química , Estilbenos/farmacología , Factores de Tiempo
8.
Cell Mol Neurobiol ; 38(4): 929-939, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-29159732

RESUMEN

Oxidative stress is a great challenge to neurons following cerebral ischemia. PGC-1α has been shown to act as a potent modulator of oxidative metabolism. In this study, the effects of ZLN005, a small molecule that activate PGC-1α, against oxygen-glucose deprivation (OGD)- or ischemia-induced neuronal injury in vitro and in vivo were investigated. Transient middle cerebral artery occlusion (tMCAO) was performed in rats and ZLN005 was administered intravenously at 2 h, 4 h, or 6 h after ischemia onset. Infarct volume and neurological deficit score were detected to evaluate the neuroprotective effects of ZLN005. Well-differentiated PC12 cells, which were subjected to OGD for 2 h followed by reoxygenation for 22 h, were used as an in vitro ischemic model. Changes in expression of PGC-1α, its related genes, and antioxidant genes were determined by real-time quantitative PCR. The results showed that ZLN005 reduced cerebral infarct volume and improved the neurological deficit in rat with tMCAO, and significantly protected OGD-induced neuronal injury in PC12 cells. Furthermore, ZLN005 enhanced expression of PGC-1α in PC12 cells and in the ipsilateral hemisphere of rats with tMCAO. Additionally, ZLN005 increased antioxidant genes, including SOD1 and HO-1, and significantly prevented the ischemia-induced decrease in SOD activity. Taking together, the PGC-1α activator ZLN005 exhibits neuroprotective effects under ischemic conditions and molecular mechanisms possibly involve activation of PGC-1α signaling pathway and cellular antioxidant systems.


Asunto(s)
Bencimidazoles/farmacología , Isquemia Encefálica/tratamiento farmacológico , Neuronas/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Coactivador 1-alfa del Receptor Activado por Proliferadores de Peroxisomas gamma/efectos de los fármacos , Animales , Antioxidantes/farmacología , Isquemia Encefálica/metabolismo , Supervivencia Celular/efectos de los fármacos , Isquemia/tratamiento farmacológico , Isquemia/metabolismo , Masculino , Neuronas/metabolismo , Estrés Oxidativo/efectos de los fármacos , Células PC12 , Ratas , Ratas Sprague-Dawley , Transducción de Señal/efectos de los fármacos
9.
Cell Mol Neurobiol ; 38(1): 53-71, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-28534246

RESUMEN

Microglia, of myeloid origin, play fundamental roles in the control of immune responses and the maintenance of central nervous system homeostasis. These cells, just like peripheral macrophages, may be activated into M1 pro-inflammatory or M2 anti-inflammatory phenotypes by appropriate stimuli. Microglia do not respond in isolation, but form part of complex networks of cells influencing each other. This review addresses the complex interaction of microglia with each cell type in the brain: neurons, astrocytes, cerebrovascular endothelial cells, and oligodendrocytes. We also highlight the participation of microglia in the maintenance of homeostasis in the brain, and their roles in the development and progression of age-related neurodegenerative disorders.


Asunto(s)
Encéfalo/metabolismo , Microglía/metabolismo , Neuronas/metabolismo , Animales , Encéfalo/patología , Sistema Nervioso Central/metabolismo , Sistema Nervioso Central/patología , Homeostasis/fisiología , Humanos , Microglía/patología , Enfermedades Neurodegenerativas/metabolismo , Enfermedades Neurodegenerativas/patología , Neuronas/patología
10.
Acta Pharmacol Sin ; 38(1): 29-40, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-27840407

RESUMEN

Recent studies focus on promoting neurite outgrowth to remodel the central nervous network after brain injury. Currently, however, there are few drugs treating brain diseases in the clinic by enhancing neurite outgrowth. In this study, we established an NGF-induced PC12 differentiation model to screen novel compounds that have the potential to induce neuronal differentiation, and further characterized 4,10-Aromadendranediol (ARDD) isolated from the dried twigs of the Baccharis gaudichaudiana plant, which exhibited the capability of promoting neurite outgrowth in neuronal cells in vitro. ARDD (1, 10 µmol/L) significantly enhanced neurite outgrowth in NGF-treated PC12 cells and N1E115 cells in a time-dependent manner. In cultured primary cortical neurons, ARDD (5, 10 µmol/L) not only significantly increased neurite outgrowth but also increased the number of neurites on the soma and the number of bifurcations. Further analyses showed that ARDD (10 µmol/L) significantly increased the phosphorylation of ERK1/2 and the downstream GSK-3ß, subsequently induced ß-catenin expression and up-regulated the gene expression of the Wnt ligands Fzd1 and Wnt3a in neuronal cells. The neurite outgrowth-promoting effect of ARDD in neuronal cells was abolished by pretreatment with the specific ERK1/2 inhibitor PD98059, but was partially reversed by XAV939, an inhibitor of the Wnt/ß-catenin pathway. ARDD also increased the expression of BDNF, CREB and GAP-43 in N1E115 cells, which was reversed by pretreatment with PD98059. In N1E115 cells subjected to oxygen and glucose deprivation (OGD), pretreatment with ARDD (1-10 µmol/L) significantly enhanced the phosphorylation of ERK1/2 and induced neurite outgrowth. These results demonstrated that the natural product ARDD exhibits neurite outgrowth-inducing activity in neurons via activation of the ERK signaling pathway, which may be beneficial to the treatment of brain diseases.


Asunto(s)
Proteína GAP-43/biosíntesis , Proteína GAP-43/metabolismo , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Neuritas/efectos de los fármacos , Sesquiterpenos/farmacología , Animales , Factor Neurotrófico Derivado del Encéfalo/biosíntesis , Células Cultivadas , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/biosíntesis , Flavonoides/farmacología , Compuestos Heterocíclicos con 3 Anillos/farmacología , Ratones , Factor de Crecimiento Nervioso/farmacología , Neuritas/metabolismo , Neuritas/ultraestructura , Fosforilación/efectos de los fármacos , Cultivo Primario de Células , Ratas , Sesquiterpenos/antagonistas & inhibidores , Sesquiterpenos de Guayano
11.
Toxicol Appl Pharmacol ; 289(2): 142-54, 2015 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-26440581

RESUMEN

The natural product totarol, a phenolic diterpenoid and a major constituent isolated from the sap of Podocarpus totara, has been reported to have a potent antimicrobial activity. In this study, we determined whether totarol possessed an additional neuroprotective activity in vitro and in vivo. We found that totarol prevented glutamate- and oxygen and glucose deprivation-induced neuronal death in primary rat cerebellar granule neuronal cells and cerebral cortical neurons. Totarol increased Akt and GSK-3ß phosphorylation, Nrf2 and heme oxygenase-1 (HO-1) protein expressions and suppressed oxidative stress by increasing GSH and SOD activities. The PI3K/Akt inhibitor LY294002 prevented totarol neuroprotective effect by suppressing the totarol-induced changes in HO-1 expression and the activities of GSH and SOD. The HO-1 inhibitor ZnPPIX also prevented totarol-increased GSH and SOD activities. In a model of acute cerebral ischemic injury in Sprague-Dawley rats, produced by occlusion of the middle cerebral artery for 2h followed by 22 h or 46 h of reperfusion, totarol significantly reduced infarct volume and improved the neurological deficit. In this model, totarol increased HO-1 expression and the activities of GSH and SOD. These observations suggest that totarol may be a novel activator of the Akt/HO-1 pathway protecting against ischemic stroke through reduction of oxidative stress.


Asunto(s)
Antioxidantes/farmacología , Encéfalo/efectos de los fármacos , Diterpenos/farmacología , Hemo Oxigenasa (Desciclizante)/biosíntesis , Infarto de la Arteria Cerebral Media/prevención & control , Neuronas/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Proteínas Proto-Oncogénicas c-akt/metabolismo , Abietanos , Animales , Encéfalo/enzimología , Encéfalo/patología , Muerte Celular/efectos de los fármacos , Hipoxia de la Célula , Células Cultivadas , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Activación Enzimática , Inducción Enzimática , Agonistas de Aminoácidos Excitadores/toxicidad , Glucosa/deficiencia , Ácido Glutámico/toxicidad , Glutatión/metabolismo , Glucógeno Sintasa Quinasa 3/metabolismo , Glucógeno Sintasa Quinasa 3 beta , Infarto de la Arteria Cerebral Media/enzimología , Infarto de la Arteria Cerebral Media/patología , Masculino , Factor 2 Relacionado con NF-E2/metabolismo , Neuronas/enzimología , Neuronas/patología , Estrés Oxidativo/efectos de los fármacos , Fosforilación , Ratas Sprague-Dawley , Transducción de Señal/efectos de los fármacos , Superóxido Dismutasa/metabolismo , Factores de Tiempo
12.
Brain Behav Immun ; 50: 298-313, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26188187

RESUMEN

Brain inflammation plays an important role in the pathophysiology of many psychiatric and neurological diseases. During brain inflammation, microglia cells are activated, producing neurotoxic molecules and neurotrophic factors depending on their pro-inflammatory M1 and anti-inflammatory M2 phenotypes. It has been demonstrated that Angiotensin II type 1 receptor blockers (ARBs) ameliorate brain inflammation and reduce M1 microglia activation. The ARB telmisartan suppresses glutamate-induced upregulation of inflammatory genes in cultured primary neurons. We wished to clarify whether telmisartan, in addition, prevents microglia activation through polarization to an anti-inflammatory M2 phenotype. We found that telmisartan promoted M2 polarization and reduced M1 polarization in LPS-stimulated BV2 and primary microglia cells, effects partially dependent on PPARγ activation. The promoting effects of telmisartan on M2 polarization, were attenuated by an AMP-activated protein kinase (AMPK) inhibitor or AMPK knockdown, indicating that AMPK activation participates on telmisartan effects. Moreover, in LPS-stimulated BV2 cells, telmisartan enhancement of M2 gene expression was prevented by the inhibitor STO-609 and siRNA of calmodulin-dependent protein kinase kinase ß (CaMKKß), an upstream kinase of AMPK. Furthermore, telmisartan enhanced brain AMPK activation and M2 gene expression in a mouse model of LPS-induced neuroinflammation. In addition, telmisartan reduced the LPS-induced sickness behavior in this in vivo model, and this effect was prevented by prior administration of an AMPK inhibitor. Our results indicate that telmisartan can be considered as a novel AMPK activator, suppressing microglia activation by promoting M2 polarization. Telmisartan may provide a novel, safe therapeutic approach to treat brain disorders associated with enhanced inflammation.


Asunto(s)
Proteínas Quinasas Activadas por AMP/metabolismo , Bloqueadores del Receptor Tipo 1 de Angiotensina II/administración & dosificación , Bencimidazoles/administración & dosificación , Benzoatos/administración & dosificación , Quinasa de la Proteína Quinasa Dependiente de Calcio-Calmodulina/metabolismo , Polaridad Celular/efectos de los fármacos , Encefalitis/metabolismo , Microglía/fisiología , Animales , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Encefalitis/inducido químicamente , Células HeLa , Humanos , Conducta de Enfermedad/efectos de los fármacos , Lipopolisacáridos/administración & dosificación , Ratones , Microglía/efectos de los fármacos , Microglía/metabolismo , Transducción de Señal/efectos de los fármacos , Telmisartán
13.
Bioorg Med Chem ; 23(4): 694-702, 2015 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-25614113

RESUMEN

A new Rhodamine B derivative (RBDPA), namely, N(1)-(2-(3',6'-bis(diethylamino)-3-oxospiro[isoindoline-1,9'-xanthen]-2-yl)ethyl)-N(4),N(4)-bis(pyridin-2-ylmethyl)succinamide, was designed, synthesized and structurally characterized to develop a chemosensor. The studies show that RBDPA exhibits high sensitivity and selectivity toward Al(3+) among many other metal cations in an ethanol/H2O (1:1, v/v, pH=7.2, HEPES buffer, 0.1mM) solution. Fluorescence microscopy experiments further demonstrate that RBDPA can be used as a fluorescent probe to detect Al(3+) in living cells.


Asunto(s)
Aluminio/análisis , Aminas/química , Colorantes Fluorescentes/química , Imagen Óptica , Ácidos Picolínicos/química , Rodaminas/química , Aminas/síntesis química , Cationes/análisis , Línea Celular , Colorantes Fluorescentes/síntesis química , Humanos , Hígado/citología , Microscopía Fluorescente , Modelos Moleculares , Ácidos Picolínicos/síntesis química , Rodaminas/síntesis química , Espectrometría de Fluorescencia
14.
Bioorg Med Chem ; 23(5): 1179-88, 2015 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-25662701

RESUMEN

A series of novel 3-([1,2,4]triazolo[4,3-a]pyridin-3-yl)-4-(indol-3-yl)-maleimides were designed, prepared and evaluated for their GSK-3ß inhibitory activities. Most compounds showed high potency to GSK-3ß inhibition with high selectivity. Among them, compounds 7c, 7f, 7h, 7l and 7m significantly reduced GSK-3ß substrate Tau phosphorylation at Ser396 in primary neurons, showing the inhibition of cellular GSK-3ß. In the in vitro neuronal injury models, compounds 7c, 7f, 7h, 7l and 7m prevented neuronal death against glutamate, oxygen-glucose deprivation and nutrient serum deprivation which are associated with cerebral ischemic stroke. In the in vivo cerebral ischemia animal model, compound 7f reduced infarct size by 15% and improved the neurological deficit following focal cerebral ischemia. These findings may provide new insights into the development of novel GSK-3ß inhibitors with potential neuroprotective activity.


Asunto(s)
Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/farmacología , Glucógeno Sintasa Quinasa 3/antagonistas & inhibidores , Maleimidas/síntesis química , Maleimidas/farmacología , Fármacos Neuroprotectores/síntesis química , Fármacos Neuroprotectores/farmacología , Animales , Inhibidores Enzimáticos/química , Glucógeno Sintasa Quinasa 3 beta , Masculino , Maleimidas/química , Modelos Moleculares , Fármacos Neuroprotectores/química , Ratas , Ratas Sprague-Dawley , Relación Estructura-Actividad
15.
Artículo en Inglés | MEDLINE | ID: mdl-38568328

RESUMEN

Anaerobic fermentation of excess sludge (ES) for hydrogen production is a crucial strategy for resource utilization and environmentally friendly treatment. However, the low hydrolysis efficiency of ES and the depletion of produced hydrogen have become the limiting factors for low hydrogen yield. This study innovatively applied the bio-based surfactant alkyl polyglucoside (APG) to enhance the efficiency of dark fermentation for hydrogen production from ES. When the APG content was 100 mg/g (calculated based on total suspended solids), the maximum hydrogen production reached 17.8 mL/g VSS, approximately 3.7 times that in the control group. Mechanistic analysis revealed that APG promoted the release of organic matter from ES. APG also facilitated the release of soluble protein and soluble polysaccharide, increasing the organic matter reduction rate to 34.8%, significantly higher than other groups. APG enhanced the accumulation of volatile fatty acids and promoted the proportion of small molecular carboxylic acids. Enzyme activity analysis revealed that APG promoted the activity of hydrolytic enzymes but inhibited the activity of hydrogen-consuming enzymes. The research results provide a green and environmentally friendly strategy for the efficient resource utilization of ES.

16.
Water Res ; 259: 121841, 2024 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-38820734

RESUMEN

The toxicity of microplastics (MPs) on freshwater plants has been widely studied, yet the influence of aged MPs remains largely unexplored. Herein, we investigated the influence of polyvinyl chloride (PVC) MPs, both before and after aging, at different environmentally relevant concentrations on Chlorella pyrenoidosa, a freshwater microalgae species widely recognized as a valuable biomass resource. During a 96-h period, both virgin and aged MPs hindered the growth of C. pyrenoidosa. The maximum growth inhibition rates were 32.40 % for virgin PVC at 250 mg/L and 44.72 % for aged PVC at 100 mg/L, respectively. Microalgae intracellular materials, i.e., protein and carbohydrate contents, consistently decreased after MP exposure, with more pronounced inhibition observed with aged PVC. Meanwhile, the MP aging significantly promoted the nitrogen uptake of C. pyrenoidosa, i.e., 1693.45 ± 42.29 mg/L (p < 0.01), contributing to the production of humic acid-like substances. Additionally, aged PVC induced lower chlorophyll a and Fv/Fm when compared to virgin PVC, suggesting a more serious inhibition of the photosynthesis process of microalgae. The toxicity of MPs to C. pyrenoidosa was strongly associated with intercellular oxidative stress levels. The results indicate that MP aging exacerbates the damage to photosynthetic performance and bioenergy production in microalgae, providing critical insights into the toxicity analysis of micro(nano)plastics on freshwater plants.


Asunto(s)
Chlorella , Microalgas , Microplásticos , Fotosíntesis , Fotosíntesis/efectos de los fármacos , Chlorella/efectos de los fármacos , Microalgas/efectos de los fármacos , Microplásticos/toxicidad , Contaminantes Químicos del Agua/toxicidad , Biomasa , Clorofila/metabolismo
17.
Int J Biol Macromol ; 262(Pt 1): 129811, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38302018

RESUMEN

Effects of fermentation by Lactobacillus Plantarum NCU116 on the antihypertensive potential of black sesame seed (BSS) and structure characteristics of fermented black sesame seed protein (FBSSP) were investigated. Angiotensin-I-converting enzyme (ACE) inhibition and zinc chelating ability of fermented black sesame seed hydrolysate (FBSSH) reached the highest of 60.78 ± 3.67 % and 2.93 ± 0.04 mg/mL at 48 h and 60 h of fermentation, respectively. Additionally, the antioxidant activities of FBSSH and surface hydrophobicity of FBSSP were increased noticeably by fermentation. The α-helix and ß-rotation of FBSSP tended to decrease and increase, respectively, during fermentation. Correlation analysis indicated strong positive relationships between ß-turn and ACE inhibition activity as well as zinc chelating ability with correlation coefficients r of 0.8976 and 0.8932. Importantly, novel ACE inhibitory peptides LLLPYY (IC50 = 12.20 µM) and ALIPSF (IC50 = 558.99 µM) were screened from FBSSH at 48 h using in silico method. Both peptides showed high antioxidant activities in vitro. Molecular docking analysis demonstrated that the hydrogen bond connected with zinc ions of ACE mainly attributed to the potent ACE inhibitory activity of LLLPYY. The findings indicated that fermentation by Lactobacillus Plantarum NCU116 is an effective method to enhance the antihypertensive potential of BSS.


Asunto(s)
Lactobacillus plantarum , Sesamum , Antihipertensivos/farmacología , Lactobacillus plantarum/metabolismo , Fermentación , Inhibidores de la Enzima Convertidora de Angiotensina/química , Antioxidantes/farmacología , Antioxidantes/metabolismo , Simulación del Acoplamiento Molecular , Péptidos/química , Zinc/metabolismo , Peptidil-Dipeptidasa A/metabolismo
18.
Mol Nutr Food Res ; 68(5): e2300586, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38299716

RESUMEN

SCOPE: Lactic acid bacteria with probiotic functions and their fermentation products play a role in regulating ulcerative colitis (UC). This study investigates the potential role of fermented soymilk (FSM4) rich in isoflavones on DSS-induced UC. METHODS AND RESULTS: Mice received 3% DSS and are supplemented daily once for 1 week by NFSM and FSM4. DSS usually causes intestinal inflammation and alters the gut microbiota. FSM4 intervention improves the UC-related inflammation and gut microbiota alteration. It considerably decreases pro-inflammatories such as TNF-α, IL-1ß, and IL-6 in serum and COX-2 and MPO in colon tissues and pathogenic bacteria (Escherichia-Shigella). This facilitates gut-healthy bacteria growth. These healthy bacteria negatively correlat with pro-inflammatory factors but positively associated with acetic acid, butyric acid, and propionic acid, which may act for PPAR-γ pathway activating and NF-κB p65 pathway inhibiting, lowering the risk of UC. Overall, FSM4 might alleviate UC and significantly reverse the dysbiosis of gut microbiota via the PPAR-γ activation. It could be a good alternative for developing functional food to protect against UC. CONCLUSION: FSM4 attenuates intestinal inflammation and modulates the SCFA-producing bacteria growth, which enable the PPAR-γ activation to alleviate the UC target, which could be a dietary intervention strategy for gut health.


Asunto(s)
Colitis Ulcerosa , Colitis , Microbioma Gastrointestinal , Probióticos , Animales , Ratones , Colitis Ulcerosa/inducido químicamente , Dextranos , Receptores Activados del Proliferador del Peroxisoma , Inflamación , Probióticos/farmacología , Ácido Butírico , Sulfatos , Sodio , Sulfato de Dextran/toxicidad , Modelos Animales de Enfermedad , Colon , Ratones Endogámicos C57BL
19.
Food Chem ; 428: 136781, 2023 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-37418882

RESUMEN

Effects of enzyme treatment on the hypertensive potential and protein structure of black sesame seed (BSS) were investigated. Compared with BSS, Angiotensin-converting enzyme (ACE) inhibition of fermented black sesame seed (FBSS) has significantly improved after acid protease processing and reached 75.39% at 2 U/g in 3 h. Meanwhile, the zinc chelating ability and antioxidant activity of FBSS hydrolysate as well as surface hydrophobicity, free sulfhydryl content, and peptide content of FBSS protein, were significantly increased. The results illustrated that this strategy promoted the protein unfolding and exposure of hydrophobic residues, thus contributing toward enzymatic hydrolysis. Secondary structure results indicated that the α-helix of FBSS protein and ß-sheet of BSS protein decreased after hydrolyzing. The differences in ACE inhibition may also result from the difference in peptide sequence except for peptide content. In conclusion, the combination of fermentation pretreatment and enzyme treatment is an effective method to enhance the antihypertensive potential of BSS.


Asunto(s)
Antihipertensivos , Sesamum , Antihipertensivos/farmacología , Sesamum/química , Fermentación , Antioxidantes/análisis , Péptidos/metabolismo , Semillas/química
20.
J Physiol Biochem ; 79(1): 47-57, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-36192581

RESUMEN

Acute myocardial infarction (AMI) is a common disease with high morbidity and mortality worldwide. However, postinfarction pathogenesis remains unclear, and it is particularly important to identify new therapeutic targets. The RNA-binding motif protein RBM3 (also known as cold-inducible protein) is known to promote translation and is associated with tumor proliferation and neuroprotection. However, little is known about the biological effects of RBM3 on myocardial infarction. In the present study, we found that RBM3 expression was significantly upregulated in ischemia-reperfusion (I/R) condition and downregulation of RBM3 inhibited autophagy and promoted apoptosis in cardiomyocytes. We confirmed that RBM3 interacts with Raptor to regulate the autophagy pathway. Taken together, these findings illustrate the protective effects of RBM3 against I/R-induced myocardial apoptosis through the autophagy pathway.


Asunto(s)
Infarto del Miocardio , Daño por Reperfusión Miocárdica , Proteínas de Unión al ARN , Proteína Reguladora Asociada a mTOR , Animales , Humanos , Apoptosis , Autofagia , Infarto del Miocardio/tratamiento farmacológico , Daño por Reperfusión Miocárdica/metabolismo , Miocitos Cardíacos/metabolismo , Reperfusión , Proteínas de Unión al ARN/metabolismo , Proteína Reguladora Asociada a mTOR/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA